Aurora Cannabis Inc. (TSE:ACB - Free Report) - Equities researchers at Atb Cap Markets increased their Q3 2025 earnings per share (EPS) estimates for Aurora Cannabis in a report released on Wednesday, November 6th. Atb Cap Markets analyst F. Gomes now anticipates that the company will earn ($0.13) per share for the quarter, up from their previous estimate of ($0.21). The consensus estimate for Aurora Cannabis' current full-year earnings is ($0.22) per share. Atb Cap Markets also issued estimates for Aurora Cannabis' Q4 2025 earnings at ($0.09) EPS, FY2025 earnings at ($0.03) EPS, FY2026 earnings at ($0.04) EPS, FY2027 earnings at ($0.07) EPS, FY2028 earnings at $0.25 EPS and FY2029 earnings at $1.17 EPS.
Aurora Cannabis Stock Performance
ACB stock traded down C$0.11 on Monday, hitting C$6.57. The company's stock had a trading volume of 358,798 shares, compared to its average volume of 1,068,843. Aurora Cannabis has a 1 year low of C$3.84 and a 1 year high of C$12.85. The company has a current ratio of 3.76, a quick ratio of 2.48 and a debt-to-equity ratio of 16.95. The stock has a market cap of C$359.12 million, a price-to-earnings ratio of -10.60 and a beta of 2.71. The firm has a 50 day moving average of C$7.71 and a two-hundred day moving average of C$8.16.
Insider Transactions at Aurora Cannabis
In other Aurora Cannabis news, Senior Officer Andre Jerome sold 7,712 shares of Aurora Cannabis stock in a transaction that occurred on Monday, September 23rd. The stock was sold at an average price of C$7.70, for a total value of C$59,382.40.
About Aurora Cannabis
(
Get Free Report)
Aurora Cannabis Inc, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products.
Recommended Stories
Before you consider Aurora Cannabis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aurora Cannabis wasn't on the list.
While Aurora Cannabis currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
